Clinical Trials Logo

Clinical Trial Summary

Acute bronchiolitis is a common, distressing illness affecting children. A virus infects the lungs, and then the airways become blocked, leading to difficulties with breathing. It is the most common reason why children are admitted to hospital, with 1-3% of all children admitted to hospital during their first winter, creating enormous strains on NHS services. The majority of those admitted with the condition are under six months of age and the associated stress for parents is considerable. After forty years of research the best treatment we have is supportive care and oxygen.

Recent research suggests that salt water, sprayed as a mist so that the children can breathe it in ('nebulised 3% hypertonic saline') might help children with acute bronchiolitis. Scientists think that the salt water changes the mucus which blocks the airways so that it can be cleared more easily. Three small research studies all suggested that a child's time in hospital could be reduced by a quarter by using this treatment. If this was true, it would be good for children, their families and the children's wards trying to cope with the large numbers admitted with bronchiolitis every year.

To decide whether this treatment should be used throughout the NHS, we need to run a randomised controlled trial of hypertonic saline in a large number of children. The trial will tell us if adding saline to usual care reduces distress in both children and parents, as well as whether it reduces the length of time they stay in hospital. We will then know if the treatment is the best thing for children with bronchiolitis and whether it provides the NHS with good value for money.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01469845
Study type Interventional
Source Sheffield Children's NHS Foundation Trust
Contact
Status Completed
Phase Phase 3
Start date October 2011
Completion date January 2014

See also
  Status Clinical Trial Phase
Completed NCT02962505 - Continuous Regional Analysis Device for Neonate Lung
Recruiting NCT02984046 - Acute Bronchiolitis and Severity Markers: Interest in Protein CC16 N/A
Completed NCT01875757 - Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life Phase 3
Completed NCT01871857 - 7% Hypertonic Saline for Acute Bronchiolitis Phase 4
Completed NCT06139029 - Comparison of 3% Normal Saline Nebulization Versus Steroid Nebulization in the Treatment of Bronchiolitis Early Phase 1
Not yet recruiting NCT03915197 - Acute Bronchiolitis in Infants and Allergic Asthma N/A
Completed NCT03171142 - Effect of Heliox on RSV Bronchiolitis Phase 3
Completed NCT04245202 - Comparison of High Flow Nasal Cannula and Standard Face Mask Oxygen Therapy in Children With Bronchiolitis N/A
Not yet recruiting NCT06441162 - Efficacy Of Combined Nebulized Hypertonic Saline and Chest Percussion Therapy in Acute Viral Bronchiolitis Phase 4
Recruiting NCT02093715 - FeNO and Cytokines in Respiratory Syncytial Virus (RSV) and Non RSV Bronchiolitis in Relation to Future Asthma N/A
Not yet recruiting NCT03880903 - Hypertonic Saline Inhalation in Acute Bronchiolitis Phase 4
Completed NCT04748159 - Effects of Prone Positioning on Vital Parameters in Infants With Acute Bronchiolitis N/A
Active, not recruiting NCT04613180 - Evaluation of the Effectiveness of Montelukast in Children With Recurrent Obstructive Bronchitis Phase 4
Recruiting NCT06321133 - High Flow Nasal Cannula Weaning in Acute Bronchiolitis N/A
Completed NCT02029040 - Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis N/A
Recruiting NCT03753802 - Evaluation of the Effects of Respiratory Physiotherapy in Infants With Moderate Acute Bronchiolitis N/A
Withdrawn NCT01660867 - Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in the Emergency Department Phase 4